James H. Finke

Palm Beach Atlantic University — United States

Medicine · Health Sciences

57h-index11.6kcitations301works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(86), Immunotherapy and Immune Responses(82), Immune cells in cancer(60), Immune Cell Function and Interaction(51), CAR-T cell therapy research(34)

Publications301 total

1381 Empirical Validity of Serum Creatinine Availability in a Community Setting and Impact of Medication Dosing
Journal of the American Pharmacists Association·2025· 1 cited
Supplementary Figure 1 from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
2023Open Access
Supplementary Table from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
2023Open Access
Supplementary Figure 1 from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
2023Open Access
Data from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
2023Open Access
Supplementary Figures 2-4 from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
2023Open Access
Data from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
2023Open Access
Supplementary Table from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
2023Open Access
Supplementary Figures 2-4 from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
2023Open Access
Supplementary Tables S1-S2 from Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
2023Open Access
Supplementary Tables S1-S2 from Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
2023Open Access
Data from Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
2023Open Access
Data from Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
2023Open Access
Supplementary Table 1 from Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained
2023Open Access
Supplementary Figure 1 from GM1 and Tumor Necrosis Factor-α, Overexpressed in Renal Cell Carcinoma, Synergize to Induce T-Cell Apoptosis
2023Open Access
Data from GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of Activated but not Resting T Cells
2023Open Access
Supplementary Figure 1 from GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of Activated but not Resting T Cells
2023Open Access
Supplementary Figure 1 from GM1 and Tumor Necrosis Factor-α, Overexpressed in Renal Cell Carcinoma, Synergize to Induce T-Cell Apoptosis
2023Open Access
Data from GM1 and Tumor Necrosis Factor-α, Overexpressed in Renal Cell Carcinoma, Synergize to Induce T-Cell Apoptosis
2023Open Access
Data from Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained
2023Open Access
page 1 of 16Next →

Frequent Co-authors

Ronald M. Bukowski(24), Patricia Rayman(23), Charles S. Tannenbaum(11), Brian I. Rini(9), Vladimir Kolenko(7), Jennifer S. Ko(6), Amy L. Richmond(6), Walter J. Storkus(6), Thomas A. Hamilton(6), Robert G. Uzzo(6), Tracy Bloom(6), Andrew C. Novick(6), Joanna Ireland(5), Paul Elson(5), Peter A. Cohen(5), Eric A. Klein(5), Raymond Tubbs(5), Raymond R. Tubbs(4), Eric D. Hsi(4), Mark Edinger(4)